Wednesday, October 22, 2014 2:07:16 PM
i dont use limit orders on penny stocks...and i guarantee you the pps will no doubt rise past where i sell it at...and im perfectly ok with that...i will buy and sell as many times as the opportunity presents itself...
"If, hypothetically, you would buy a lot more shares of KBLB at these prices, the growth of that purchase would be astronomical by the end of 2015 than any other stock you can find. "
then the money i will make trading it will be astronomical as well...if your scenario proves correct, its quite possible it may not be as much as holding the stock, but then ive been profiting while not having my money tied up in a dead stock for years as well... it all evens out...
"By the way, since you claim that there are so many other places to make a great return, why do you not tell us your top choice, so we can do a total return comparison by the end of 2015 between your top choice and KBLB. We will see which stock wins. "
the money i trade with is put in all those "many other places"...sometimes many times over...i am not looking for a lottery ticket type of stock...you are asking a trader to pick one stock to park money for a great return...thats not what i do...
besides, that question is asked once a year...and if i had chosen a bank savings account, i would have won every single year...lol
"Of course, I know which one will win, but we will see"
yup...that was said every year as well...
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM